10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q3 2012

Filing Information

Form Type	10-Q
Accession Number	`0001255294-12-000500`
Period End Date	20120531
Filing Date	20120716
Fiscal Year	2012
Fiscal Period	Q3
XBRL Instance	gair-20120531.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 43 Income Statement 28 Cash Flow Statement 20

Balance Sheet 43 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, Par Value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par Value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`Cash`	-	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$33.06K	USD	Point-in-time
Cash	`Cash`	$10.00K	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	-	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$72.47K	USD	Point-in-time
Common Stock, Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.00K	USD	Point-in-time
Common Stock, Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$105.52K	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	90.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	90.00M	shares	Point-in-time
Fixed Assets, net of accumulated depreciation of $14,168 and $0, respectively	`PropertyPlantAndEquipmentNet`	$212.50K	USD	Point-in-time
Fixed Assets, net of accumulated depreciation of $14,168 and $0, respectively	`PropertyPlantAndEquipmentNet`	$198.33K	USD	Point-in-time
Total assets	`Assets`	$303.86K	USD	Point-in-time
Common Stock, Issued	`CommonStockSharesIssued`	10.00M	shares	Point-in-time
Total assets	`Assets`	$222.50K	USD	Point-in-time
Common Stock, Issued	`CommonStockSharesIssued`	13.50M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$130.24K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$7.37K	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$548.00	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$10.33K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.92K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$140.57K	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$212.81K	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$212.81K	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding at May 31, 2012 and August 31, 2011, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding at May 31, 2012 and August 31, 2011, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 90,000,000 shares authorized, 13,500,000 and 10,000,000 shares issued and outstanding at May 31, 2012 and August 31, 2011, respectively	`CommonStockValue`	$10.00K	USD	Point-in-time
Common stock, $0.001 par value; 90,000,000 shares authorized, 13,500,000 and 10,000,000 shares issued and outstanding at May 31, 2012 and August 31, 2011, respectively	`CommonStockValue`	$13.50K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$31.50K	USD	Point-in-time
Deficit accumulated during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$-8.23K	USD	Point-in-time
Deficit accumulated during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$-94.53K	USD	Point-in-time
Total stockholders (deficit) equity	`StockholdersEquity`	$1.76K	USD	Point-in-time
Total stockholders (deficit) equity	`StockholdersEquity`	$-49.53K	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$303.86K	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$222.50K	USD	Point-in-time

Income Statement 28 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$86.15K	USD	3 Qtrs
Revenue	`Revenues`	$36.43K	USD	1 Quarter
Aircraft maintenance and fee	`EquipmentExpense`	$15.85K	USD	1 Quarter
Aircraft maintenance and fee	`EquipmentExpense`	$29.83K	USD	3 Qtrs
Fuel and oil	`ProductionCosts`	$19.95K	USD	3 Qtrs
Fuel and oil	`ProductionCosts`	$9.91K	USD	1 Quarter
Management fees	`ManagementFees`	$6.19K	USD	1 Quarter
Management fees	`ManagementFees`	$15.26K	USD	3 Qtrs
Professional fees	`ProfessionalFees`	$83.43K	USD	3 Qtrs
Professional fees	`ProfessionalFees`	$34.79K	USD	1 Quarter
Depreciation	`AccumulatedDepreciationDepletionAndAmortizationWritedownOfPropertyPlantAndEquipment`	$14.17K	USD	3 Qtrs
Depreciation	`AccumulatedDepreciationDepletionAndAmortizationWritedownOfPropertyPlantAndEquipment`	$5.31K	USD	1 Quarter
Administrative fees	`AdministrativeFees`	$25.00	USD	3 Qtrs
Administrative fees	`AdministrativeFees`	-	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$72.06K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$162.66K	USD	3 Qtrs
Net loss from operations	`OperatingIncomeLoss`	$-35.63K	USD	1 Quarter
Net loss from operations	`OperatingIncomeLoss`	$-76.51K	USD	3 Qtrs
Interest expense	`InterestExpense`	$-3.23K	USD	1 Quarter
Interest expense	`InterestExpense`	$-9.78K	USD	3 Qtrs
Total other income (expense)	`OtherExpenses`	$-9.78K	USD	3 Qtrs
Total other income (expense)	`OtherExpenses`	$-3.23K	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperations`	$-86.29K	USD	3 Qtrs
Net loss	`IncomeLossFromContinuingOperations`	$-38.86K	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	3 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	12.13M	shares	1 Quarter
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	10.72M	shares	3 Qtrs

Cash Flow Statement 20 line items

Line Item	Tag	Value	Unit	Period
Net (loss)	`NetIncomeLoss`	$-86.29K	USD	3 Qtrs
Depreciation	`Depreciation`	$14.17K	USD	3 Qtrs
(Increase)/Decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-72.47K	USD	3 Qtrs
Increase/(Decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$122.87K	USD	3 Qtrs
Increase/(Decrease) in accrued interest	`IncreaseDecreaseInInterestPayableNet`	$9.78K	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-11.94K	USD	3 Qtrs
Purchase of helicopter	`PaymentsToAcquirePropertyPlantAndEquipment`	$-212.50K	USD	3 Qtrs
Net cash (used) in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-212.50K	USD	3 Qtrs
Proceeds from loan payable	`ProceedsFromNotesPayable`	$212.81K	USD	3 Qtrs
Common stock issued for cash	`ProceedsFromIssuanceOrSaleOfEquity`	$35.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$35.00K	USD	3 Qtrs
Net increase in cash	`CashPeriodIncreaseDecrease`	$23.06K	USD	3 Qtrs
Cash at beginning of period	`Cash`	-	USD	Point-in-time
Cash at beginning of period	`Cash`	$33.06K	USD	Point-in-time
Cash at beginning of period	`Cash`	$10.00K	USD	Point-in-time
Cash at end of period	`Cash`	-	USD	Point-in-time
Cash at end of period	`Cash`	$33.06K	USD	Point-in-time
Cash at end of period	`Cash`	$10.00K	USD	Point-in-time
Cash paid for interest	`InterestPaid`	-	USD	3 Qtrs
Cash paid for taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.